Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;134(5):e345.
doi: 10.1016/j.amjmed.2021.01.009.

Unproven Therapy Algorithms for Early SARS-CoV-2 Infection Are Dangerous

Rodrigo Diaz Olmos  1 , Felício Lopes Roque  2
Affiliations
Comment

Unproven Therapy Algorithms for Early SARS-CoV-2 Infection Are Dangerous

Rodrigo Diaz Olmos et al. Am J Med. 2021 May.
No abstract available

PubMed Disclaimer

Comment in

  • The Reply.
    McCullough PA. McCullough PA. Am J Med. 2021 May;134(5):e346-e347. doi: 10.1016/j.amjmed.2021.01.013. Am J Med. 2021. PMID: 33962710 Free PMC article. No abstract available.

Comment on

References

    1. McCullough PA, Kelly RJ, Ruocco G, et al. Pathophysiological basis and rationale for early outpatient treatment of SARS-CoV-2 (COVID-19) infection. Am J Med. 2021;134:16–22. doi: 10.1016/j.amjmed.2020.07.003. - DOI - PMC - PubMed
    1. Skipper CP, Pastick KA, Engen NW, et al. Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial. Ann Intern Med. 2020;173(8):623–631. doi: 10.7326/M20-4207. - DOI - PMC - PubMed
    1. Cavalcanti AB, Zampieri FG, Rosa RG, et al. Hydroxychloroquine with or without azithromycin in mild-to-moderate COVID-19. N Engl J Med. 2020;383:2041–2052. doi: 10.1056/NEJMoa2019014. - DOI - PMC - PubMed
    1. Doi Y, Hibino M, Hase R, et al. A prospective randomized, open-label trial of early versus late favipiravir therapy in hospitalized patients with COVID-19. Antimicrob Agents Chemother. 2020;64(12) doi: 10.1128/AAC.01897-20. e01897-20. - DOI - PMC - PubMed
    1. RECOVERY Collaborative Group, Horby P, Lim WS, et al. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report [e-pub ahead of print]. N Engl J Med. Accessed January 15, 2021. doi: NEJMoa2021436. - PubMed